Advertisement

Reactions Weekly

, Volume 1734, Issue 1, pp 403–403 | Cite as

Pembrolizumab

Increased alanine transaminase: case report
Case report
  • 11 Downloads

Reference

  1. Menon LL, et al. Safety of pembrolizumab while commencing treatment for hepatitis C with Harvoni (ledipasvir and sofosbuvir). Internal Medicine Journal 48: 1542-1543, No. 12, Dec 2018. Available from: URL: http://doi.org/10.1111/imj.14131 - AustraliaCrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations